John Lebbos
Partner, Commercial Strategy Consulting
John Lebbos, MD is a Partner in Clarivate’s Commercial Strategy Consulting team.
He is currently a practice leader in Product and Market Opportunity Assessments & Strategy and has over 20 years of experience supporting clients with product and therapeutic area strategy, functional patient journey analysis, opportunity and market assessments, disease area analysis, sales forecasting, and portfolio planning/strategy.
Formerly a Vice President in DRG’s infectious disease syndicated research group, Dr. Lebbos led the Infectious Disease research team and has had over 20 years of experience conducting market analysis, opportunity assessments and prioritization and product strategy.
Dr. Lebbos received his medical degree from the University of Massachusetts. Prior to pursuing his medical degree, he attended Tufts University where he graduated summa cum laude in chemical engineering.
Latest news
Clarivate Library Innovation Awards Launch to Celebrate Global Library Excellence
Awards open to ELUNA, IGeLU and IUG members London, U.K. December 15, 2025: Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of the inaugural…
New Clarivate Report Reveals Mainland China as Emerging Global Biopharma Innovation Leader
Out-Licensing Deals Reach $50 Billion as Chinese Biopharma Innovators Drive Breakthrough Science LONDON, U.K. December 8, 2025 Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, in partnership…